Encompass Health Corporation (EHC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Encompass Health Corporation  (NYSE: EHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Encompass Health's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Encompass Health's ROI in the second quarter of 2026?
Encompass Health Corporation achieved a return on average invested assets (ROI) of 12.09 % in its second quarter of 2026, this is above EHC's average return on investment of 9.49%.
Encompass Health Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $6 billion

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 24 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 578 to 624.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 21.76 % 12.33 % 12.12 % 11.36 % 8.34 %
Y / Y Net Income Change TTM 20.3 % 23.92 % 65.81 % 145.3 % 372.83 %
Investment (TTM) in Millions 8,693 6,463 6,280 6,130 5,946
Return On Investment (TTM) 12.09 % 13.07 % 12.56 % 12.26 % 12.24 %
EHC's Overall Ranking # 624 # 578 # 478 # 449 # 446
Seq. Investment Change TTM 11.07 % 2.69 % 2.83 % 3.8 % 2.47 %
Seq. Net Income Change TTM 2.78 % 6.81 % 5.4 % 3.97 % 5.87 %
Net Income (TTM) in Millions 833 811 759 720 693

EHC Company Profile >> Back to EHC Roi Comparisons >> See Annual EHC Return On Investment



Return On Investment EHC's Ranking
Within: No.
Industry # 4
Sector # 25
Overall # 624

Return On Investment Statistics
High Average Low
20.01 %
9.49 %
6.13 %
(Dec 31 2013)   (Sep 30 2020)







Financial Statements
Encompass Health's II. Quarter Investments $ 8,693 Millions EHC's Balance sheet
Encompass Health's II. Quarter Income $ 207 Millions Quarterly EHC's Income Statement
EHC's Income by Division See EHC's Income by Division


EHC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 5,930 5,399 5,163 4,778 5,816
Y / Y Investment Growth 9.84 % 4.57 % 8.06 % -17.85 % 6.39 %
Net Income in Millions 759 597 463 366 517
Y / Y Net Income Growth 27.24 % 28.86 % 26.54 % -29.25 % 40.24 %
Annual Return On Investment 12.8 % 11.05 % 8.97 % 7.66 % 8.89 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 12.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EHC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EHC's Competitors
Subscribers only: Roi for Encompass Health's Suppliers
Subscribers only: Return On Investment for EHC's Customers

Other Ratios
EHC's Roa EHC's Inventory Turnover Ratio EHC's Growth Rates EHC's Dividend Statistics
EHC's Profitability Ratios EHC's Asset Turnover Ratio EHC's Dividend Growth
EHC's Roe EHC's Valuation Ratios EHC's Financial Strength Ratios EHC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %

Date modified: 2026-09-12T06:19:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.